Document is current
Any future updates will be listed below
-
Authors
Biquard, Louise
Rautou, Pierre-Emmanuel https://orcid.org/0000-0001-9567-1859
- License Information
-
More Information
Article History
Received: 9 August 2023
Accepted: 30 September 2023
First Online: 9 November 2023
Declarations
:
: PER has received research funding from Terrafirma and acted as consultant for Hemostod, Mursla, Genfit, Boehringer Ingelheim and Abbelight, and received speaker fees from Tillots pharma and AbbVie.
Free to read: This content has been made available to all.
